This article covers Ketoconazole, available as a generic medication and marketed under brand names such as Nizoral. It is an antifungal agent classified within the Antifungals therapeutic group and is supplied as a 200 mg oral pill. In Hong Kong, ketoconazole is a prescription-only product regulated by the Department of Health.
Ketoconazole belongs to the azole class of antifungals. It inhibits the fungal enzyme lanosterol 14α-demethylase, a key step in the synthesis of ergosterol, an essential component of fungal cell membranes. By blocking ergosterol production, the drug destabilizes the membrane, leading to increased permeability and eventual cell death. Oral ketoconazole is absorbed from the gastrointestinal tract, reaches peak plasma concentrations within 1-2 hours, and has a half-life of approximately 8 hours. The medication is extensively metabolized in the liver and excreted mainly in the feces.
Ketoconazole is approved in many jurisdictions for systemic fungal infections caused by susceptible yeasts and molds, including:
In Hong Kong, the Department of Health permits oral ketoconazole for these indications when the benefits outweigh the risk of liver toxicity. The drug is not indicated for superficial skin infections, which are treated with topical formulations.
Who Should Use Ketoconazole?
Absolute Contraindications
Relative Contraindications
Special Populations
Major Interactions - Ketoconazole is a potent inhibitor of the CYP3A4 enzyme. It can increase plasma concentrations of drugs such as:
Cyclosporine, sirolimus, and tacrolimus (immunosuppressants).
Midazolam, triazolam, and other benzodiazepines.
Statins metabolized by CYP3A4 (e.g., simvastatin, lovastatin), raising the risk of myopathy.
Moderate Interactions - May require dose adjustment or increased monitoring:
Warfarin (possible increased INR).
Oral contraceptives (reduced effectiveness).
Patients should disclose all medications, including over-the-counter products and herbal supplements, before starting ketoconazole.
This article provides educational information about Ketoconazole and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Ketoconazole can increase blood levels of statins that are metabolized by CYP3A4, such as simvastatin and lovastatin, potentially leading to muscle toxicity. If both drugs are required, a healthcare provider may choose a statin with a different metabolic pathway or adjust the dose.
Mild hepatic impairment does not automatically preclude use, but liver enzymes should be checked before starting and monitored regularly. Any significant rise in ALT or AST warrants dose reassessment or discontinuation.
Take the missed tablet as soon as you remember, unless it is almost time for the next scheduled dose. Do not double up; maintain the once-daily schedule and continue as directed.
Certain herbs, such as St. John’s wort, induce CYP3A4 and can reduce ketoconazole efficacy. Conversely, grapefruit juice can inhibit CYP3A4, potentially raising ketoconazole levels. Discuss all supplements with your pharmacist.
Yes, provided the cabinet remains dry and the temperature stays within the recommended range (15-30 °C). Avoid areas with high humidity or direct heat sources.
Safety concerns, especially the risk of severe hepatotoxicity and adrenal suppression, have led many guidelines to favor newer azoles (e.g., fluconazole, itraconazole) for most infections. Oral ketoconazole is reserved for specific cases where alternatives are unsuitable.
Ketoconazole is not listed as a prohibited substance by the World Anti-Doping Agency (WADA). However, athletes should verify with their sport’s governing body, as formulations containing prohibited excipients may exist.
The oral tablet treats systemic fungal infections by reaching the bloodstream, while the shampoo is a topical preparation aimed at scalp dandruff and seborrheic dermatitis. Their concentrations, absorption, and safety profiles differ markedly.
Treatment length varies by infection type; for chronic pulmonary histoplasmosis, therapy may extend 6-12 months, whereas blastomycosis often requires 3-6 months. The prescribing clinician determines duration based on clinical response.
A low-fat meal is recommended to improve absorption without excessively increasing hepatic exposure. Avoid excessive alcohol and discuss any special diets with your healthcare provider.